Cargando…

Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review

Interface infectious keratitis (IIK) is a novel corneal infection that may develop after any type of lamellar keratoplasty. Onset of infection occurs in the virtual space between the graft and the host where it may remain localised until spreading with possible risk of endophthalmitis. A literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontana, Luigi, Moramarco, Antonio, Mandarà, Erika, Russello, Giuseppe, Iovieno, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579547/
https://www.ncbi.nlm.nih.gov/pubmed/30355718
http://dx.doi.org/10.1136/bjophthalmol-2018-312938
_version_ 1783427877123915776
author Fontana, Luigi
Moramarco, Antonio
Mandarà, Erika
Russello, Giuseppe
Iovieno, Alfonso
author_facet Fontana, Luigi
Moramarco, Antonio
Mandarà, Erika
Russello, Giuseppe
Iovieno, Alfonso
author_sort Fontana, Luigi
collection PubMed
description Interface infectious keratitis (IIK) is a novel corneal infection that may develop after any type of lamellar keratoplasty. Onset of infection occurs in the virtual space between the graft and the host where it may remain localised until spreading with possible risk of endophthalmitis. A literature review identified 42 cases of IIK. Thirty-one of them occurred after endothelial keratoplasty and 12 after deep anterior lamellar keratoplasty. Fungi in the form of Candida species were the most common microorganisms involved, with donor to host transmission of infection documented in the majority of cases. Donor rim cultures were useful to address the infectious microorganisms within few days after surgery. Due to the sequestered site of infection, medical treatment, using both topical and systemic antimicrobials drugs, was ineffective on halting the progression of the infection. Injection of antifungals, right at the graft–host interface, was reported successful in some cases. Spreading of the infection with development of endophthalmitis occurred in five cases after Descemet stripping automated endothelial keratoplasty with severe sight loss in three cases. Early excisional penetrating keratoplasty showed to be the treatment with the highest therapeutic efficacy, lowest rate of complications and greater visual outcomes.
format Online
Article
Text
id pubmed-6579547
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65795472019-07-02 Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review Fontana, Luigi Moramarco, Antonio Mandarà, Erika Russello, Giuseppe Iovieno, Alfonso Br J Ophthalmol Review Interface infectious keratitis (IIK) is a novel corneal infection that may develop after any type of lamellar keratoplasty. Onset of infection occurs in the virtual space between the graft and the host where it may remain localised until spreading with possible risk of endophthalmitis. A literature review identified 42 cases of IIK. Thirty-one of them occurred after endothelial keratoplasty and 12 after deep anterior lamellar keratoplasty. Fungi in the form of Candida species were the most common microorganisms involved, with donor to host transmission of infection documented in the majority of cases. Donor rim cultures were useful to address the infectious microorganisms within few days after surgery. Due to the sequestered site of infection, medical treatment, using both topical and systemic antimicrobials drugs, was ineffective on halting the progression of the infection. Injection of antifungals, right at the graft–host interface, was reported successful in some cases. Spreading of the infection with development of endophthalmitis occurred in five cases after Descemet stripping automated endothelial keratoplasty with severe sight loss in three cases. Early excisional penetrating keratoplasty showed to be the treatment with the highest therapeutic efficacy, lowest rate of complications and greater visual outcomes. BMJ Publishing Group 2019-03 2018-10-24 /pmc/articles/PMC6579547/ /pubmed/30355718 http://dx.doi.org/10.1136/bjophthalmol-2018-312938 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Review
Fontana, Luigi
Moramarco, Antonio
Mandarà, Erika
Russello, Giuseppe
Iovieno, Alfonso
Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title_full Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title_fullStr Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title_full_unstemmed Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title_short Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
title_sort interface infectious keratitis after anterior and posterior lamellar keratoplasty. clinical features and treatment strategies. a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579547/
https://www.ncbi.nlm.nih.gov/pubmed/30355718
http://dx.doi.org/10.1136/bjophthalmol-2018-312938
work_keys_str_mv AT fontanaluigi interfaceinfectiouskeratitisafteranteriorandposteriorlamellarkeratoplastyclinicalfeaturesandtreatmentstrategiesareview
AT moramarcoantonio interfaceinfectiouskeratitisafteranteriorandposteriorlamellarkeratoplastyclinicalfeaturesandtreatmentstrategiesareview
AT mandaraerika interfaceinfectiouskeratitisafteranteriorandposteriorlamellarkeratoplastyclinicalfeaturesandtreatmentstrategiesareview
AT russellogiuseppe interfaceinfectiouskeratitisafteranteriorandposteriorlamellarkeratoplastyclinicalfeaturesandtreatmentstrategiesareview
AT iovienoalfonso interfaceinfectiouskeratitisafteranteriorandposteriorlamellarkeratoplastyclinicalfeaturesandtreatmentstrategiesareview